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Abstract
As many as 20–55% of patients with a history of traumatic brain injury (TBI) experience 
chronic endocrine dysfunction, leading to impaired quality of life, impaired rehabilitation 
efforts and lowered life expectancy. Endocrine dysfunction after TBI is thought to result 
from acceleration–deceleration forces to the brain within the skull, creating enduring 
hypothalamic and pituitary neuropathology, and subsequent hypothalamic–pituitary 
endocrine (HPE) dysfunction. These experiments were designed to test the hypothesis 
that a single diffuse TBI results in chronic dysfunction of corticosterone (CORT), a 
glucocorticoid released in response to stress and testosterone. We used a rodent model 
of diffuse TBI induced by midline fluid percussion injury (mFPI). At 2 months postinjury 
compared with uninjured control animals, circulating levels of CORT were evaluated at 
rest, under restraint stress and in response to dexamethasone, a synthetic glucocorticoid 
commonly used to test HPE axis regulation. Testosterone was evaluated at rest. Further, 
we assessed changes in injury-induced neuron morphology (Golgi stain), neuropathology 
(silver stain) and activated astrocytes (GFAP) in the paraventricular nucleus (PVN) of the 
hypothalamus. Resting plasma CORT levels were decreased at 2 months postinjury and 
there was a blunted CORT increase in response to restraint induced stress. No changes in 
testosterone were measured. These changes in CORT were observed concomitantly with 
altered complexity of neuron processes in the PVN over time, devoid of neuropathology 
or astrocytosis. Results provide evidence that a single moderate diffuse TBI leads to 
changes in CORT function, which can contribute to the persistence of symptoms related 
to endocrine dysfunction. Future experiments aim to evaluate additional HP-related 
hormones and endocrine circuit pathology following diffuse TBI.
Introduction
Traumatic brain injury (TBI) is a major cause of 
death and disability throughout the world with few 
pharmacological treatments for the individuals who 
suffer from lifelong neurological symptoms associated 
with TBI. Brain injuries are the predominant injury 
of soldiers participating in Operation Iraqi Freedom 
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(OIF) and Operation Enduring Freedom (OEF) combat 
operations, with 46% screening positive for TBI (1). TBI 
is initiated by the unexpected impact of mechanical 
force(s) to the head or brain. The ensuing postinjury 
cellular cascades lead to the development of pathological 
processes over time (2). Onset of symptoms begins within 
minutes to hours after impact and can contribute to the 
development of long-lasting neurological impairments. 
Clinically prevalent symptomology includes somatic, 
cognitive and emotional impairments, with chronic 
endocrine dysfunction becoming increasingly recognized 
as a clinical issue (3, 4, 5).
Endocrine dysfunction after TBI can be attributed to 
the acceleration and deceleration of the brain inside the 
skull resulting in neuropathology, including hemorrhage, 
necrosis and fibrosis of the pituitary, infundibulum 
and hypothalamus (6). Functionally, the pituitary is 
the ‘master gland’ controlling growth, reproduction, 
adrenal regulation, water balance and thyroid function 
through secretion of trophic peptides into the circulatory 
system. Together, the hypothalamus and pituitary 
form the central component of the hypothalamic–
pituitary–endocrine (HPE) axis. Structural damage to 
these regions can contribute to the manifestation of 
transient and chronic endocrine dysfunction along with 
other associated clinical phenotypes, indicative of TBI 
being a chronic disease process rather than an acute 
event (2, 7, 8).
Chronic endocrine dysfunction can be defined 
as long-lasting changes in the production, release, 
circulation and/or regulation of hormones that result 
in one or more symptoms including emotional liability, 
anxiety, aggressiveness, sexual dysfunction, abdominal 
weight gain, memory impairment, lethargy and decreased 
stamina (9). In as many as 20–55% of patients with a 
history of TBI (10, 11, 12, 13, 14, 15), chronic endocrine 
dysfunction is sufficiently severe enough to impair 
quality of life and impede rehabilitation efforts (6, 16), 
and in rare instances, increases risk for mortality (17, 18, 
19). Pituitary hormone deficiencies or hypopituitarism, 
to a limited extent, are reported in TBI survivors, but the 
presentation of clinical symptoms depend heavily on the 
magnitude of specific hormone deficiency (20, 21, 22). 
As such, TBI survivors can present with deficiencies 
in one or more hormones, including corticotropins, 
growth hormones, thyrotropins, and gonadotropins (20). 
The variation of hormones disrupted could be based 
on the type (blast, diffuse, penetrating), mechanics 
(direction/force of impact) or dynamics (single, repetitive) 
of the injury, as well as pre-existing conditions (genetic 
predisposition) (23, 24, 25, 26, 27, 28). Recent longitudinal 
studies support the idea that a severe injury is more likely 
to result in chronic endocrine dysfunction, as opposed to 
a mild injury; however, endocrine dysfunction manifests 
across the brain injury severity spectrum (15). Injury-
induced endocrine dysfunction can be concomitant with 
and potentially augment clinical symptoms commonly 
associated with postconcussive syndrome and post-
traumatic stress disorder (PTSD) (22, 29). While the 
prevalence of endocrine dysfunction is reported in 
the clinical literature, few experimental models have 
elucidated the persistence and pathological basis of 
mild-moderate diffuse brain injury-induced endocrine 
dysfunction (9, 30).
Previous data from our laboratory indicate that 
under normal conditions, a non-noxious behavioral 
task does not increase levels of corticosterone (CORT), 
a steroid released by the adrenal glands in response 
to adrenocorticotropin hormone (ACTH) from the 
anterior pituitary (31). However, rats with mild to 
moderate diffuse TBI respond to the non-noxious 
whisker nuisance task (WNT) with a change in the 
allodynic response accompanied by increases in levels 
or corticosterone (CORT). Other investigators also report 
CORT dysregulation following focal brain injury using 
controlled cortical impact (CCI) (32, 33, 34, 35). These 
data support that rodents can experience endocrine 
dysfunction after TBI. The following experiments were 
designed to develop this profile of endocrine dysfunction 
in a rodent model of diffuse brain injury induced by 
midline fluid percussion. Further, we assessed changes 
in injury-induced neuron morphology, neuropathology 
(silver stain), and astrocyte activation (GPAP) in the 
paraventricular nucleus (PVN) of the hypothalamus, a 
region responsible for initiating the release of CORT from 
the adrenal glands via corticotropin-releasing hormone 
(CRH) and ACTH from the anterior pituitary. Multiple 
assessments (i.e. hormonal, behavioral and histological) 
were made at chronic time points postinjury to determine 
whether ongoing reparative processes could contribute to 
late-onset deficits. We hypothesized that diffuse TBI would 
lead to chronic deficiencies in CORT and testosterone, 
which are regulated by the hypothalamic–pituitary–
adrenal axis and hypothalamic–pituitary–gonadal axis, 
respectively. Furthermore, we predicted an increased 
sensory sensitivity in brain-injured rats assessed by the 
whisker nuisance task (31). Finally, we predicted ongoing 
pathology in PVN neurons of the hypothalamus.
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Methods
Study design
The following experiments used four cohorts of rats. 
Cohort one was used to assess midline fluid percussion 
injury (mFPI) on weight change, sensory sensitivity 
measured by the whisker nuisance task, neuroendocrine 
hormone levels of CORT and testosterone and 
dexamethasone treatment. Cohorts two, three and four 
were used to assess brain injury-induced changes to the 
PVN following mFPI using Golgi stain, silver stain and 
GFAP immunohistochemistry. All animal studies were 
conducted in accordance with the guidelines established 
by the internal IACUC (Institutional Animal Care and 
Use Committee) and the NIH guidelines for the care and 
use of laboratory animals. Studies are reported following 
the ARRIVE (Animal Research: Reporting In Vivo 
Experiments) guidelines. Randomization of animals was 
achieved by assigning animals to treatment groups before 
the initiation of the study to ensure equal distribution 
across groups. A power analysis was performed to 
calculate group sizes to enable statistically robust 
detection of injury-induced deficits while minimizing 
the number of animals. This calculation was based on 
preliminary data and previously published work from 
our group. Data collection stopped at predetermined 
final endpoints based on days postinjury (DPI) for each 
animal. Four animals were excluded from the study 
because postoperative weight decreased by 10% of 
presurgical weight or visible signs of pain or discomfort 
beyond 5  DPI were observed. All animal behavior was 
scored by investigators blinded to the treatment groups. 
Data sets were screened using the extreme studentized 
deviate method for significant outliers.
Animals
Adult male Sprague Dawley rats (Harlan Laboratories, 
Inc., Indianapolis, IN) were used for all experiments. 
Rats were housed in a 12 h light:12 h darkness cycle 
(06:00/18:00 h) at a constant temperature (23 ± 2°C) 
with food and water available ad libitum according 
to the Association for Assessment and Accreditation 
of Laboratory Animal Care International. Rats were 
acclimated to their environment following shipment 
for at least 1 week before any experiments. After surgery, 
rats were evaluated daily for postoperative care by 
a physical examination and documentation of each 
animal’s condition.
Midline fluid percussion injury (mFPI)
Rats (350–370 g) were subjected to midline fluid percussion 
injury (mFPI) consistent with methods described 
previously (31, 36, 37, 38, 39). Rats were anesthetized 
using 5% isoflurane in 100% oxygen for 5 min and the 
head of the rat was placed in a stereotaxic frame with 
continuously delivered isoflurane at 2.5% via nosecone. 
While anesthetized, body temperature was maintained 
using a Deltaphase isothermal heating pad (Braintree 
Scientific Inc, Braintree, MA, USA). A midline incision 
was made exposing bregma and lambda, and fascia was 
removed from the surface of the skull. A trephine (4.8 mm 
outer diameter) was used for the craniotomy, centered on 
the sagittal suture between bregma and lambda without 
disruption of the dura. An injury cap prepared from the 
female portion of a Luer-Loc needle hub was fixed over 
the craniotomy using cyanoacrylate gel and methyl-
methacrylate (Hygenic Corp, Akron, OH, USA). The 
incision was sutured at the anterior and posterior edges 
and topical Lidocaine ointment was applied. Rats were 
placed in a heated recovery cage and monitored until 
ambulatory.
For injury induction, rats were reanesthetized 
(60–90 min after surgery) with 5% isoflurane delivered 
for 5 min. The dura was visually inspected through the 
hub to make sure it was intact with no debris. The hub 
was then filled with normal saline and attached to the 
male end of the fluid percussion device (Custom Design 
and Fabrication, Virginia Commonwealth University, 
Richmond, VA, USA). An injury of moderate severity for 
our injury model (2.1 atm) was administered by releasing 
the pendulum onto the fluid-filled cylinder. Sham-injured 
rats underwent the same surgical procedures except 
the pendulum was not released. Rats were monitored 
for the presence of a forearm fencing response, and 
righting reflex times were recorded for the injured rats 
as indicators of injury severity (40). The righting reflex 
time is the total time from the initial impact until the 
rat spontaneously rights itself from a supine position. 
The fencing response is a tonic posturing characterized 
by extension and flexion of opposite arms that has been 
validated as an overt indicator of injury severity (40). The 
injury hub was removed and the brain was inspected for 
uniform herniation and integrity of the dura. The dura 
was intact in all rats; none were excluded as technical 
failures. The incision was cleaned using saline and closed 
using sutures. Moderate brain-injured rats had righting 
reflex recovery times greater than 6 min and a positive 
fencing response. Sham-injured rats recovered a righting 
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reflex within 20 s. After spontaneously righting, rats 
were placed in a heated recovery cage and monitored 
until ambulatory (approximately 5–15 min) before being 
returned to their cage. Adequate measures were taken to 
minimize pain or discomfort.
Post-operative weights
The weights of each rat were recorded on the day of 
surgery. Following surgery, animals were postoperatively 
monitored for the first 3 days postinjury. This monitoring 
included a physical examination, thorough examination 
of the suture site and evaluation of changes in 
postoperative weight. Before tissue collection, terminal 
weights were recorded at 58 DPI.
Behavioral testing
Whisker nuisance task Protocols were conducted 
as described previously (31, 41), with the exception of 
baseline whisker nuisance scores being collected before 
surgical procedures to induce mFPI. A plastic test cage 
(16.5 × 38.1 × 55.9 cm) lined with an absorbent pad was 
used. Rats were acclimated to the test cage for 5 min before 
testing. Testing involved manually stimulating the whiskers 
of both mystaical pads with a wooden applicator stick for 
three periods of 5 min with ≤1 min of nonstimulation 
between periods. Animals were tested individually and the 
absorbent pad and wooden applicator stick were replaced 
for each animal after cleaning the test cage. For each 5-min 
period, observations were made regarding the predominant 
observed behavior. These observations were categorized as 
(i) movement, (ii) stance and body position, (iii) breathing 
quality, (iv) whisker position, (v) whisking response, (vi) 
evading stimulation, (vii) response to stick presentation 
and (viii) grooming response. Normal behavior for each 
category consisted of those typically seen in uninjured 
animals during stimulation and was recorded as a score 
of zero. Meaningful abnormal behaviors expressed in 
response to whisker stimulation were assigned scores of 
1–2, depending on degree of expression. The maximum 
whisker nuisance score was 16 (two points for each of eight 
categories). Higher scores indicate abnormal responses to 
the stimulation and lower scores indicate normal responses.
Restraint stress and blood collection
A preinjury blood sample (baseline) was taken from 
each rat before mFPI or sham injury. The day of 
surgery (between 08:45 and 12:00 h), rats were 
removed from their cage and anesthetized for 5 min 
with isoflurane. Immediately following anesthesia, 
rats were secured in a stereotaxic frame and blood 
collection (250 µL) through a tail vein occurred. At 54 
and 56 DPI, rats underwent restraint stress and blood 
sampling. Samples were obtained in the acute period 
immediately following light onset (initiated between 
07:30 and 09:50 h) to control for corticosterone having 
diurnal peaks. A rat was transported in its home cage 
to procedure room, and placed tightly into flat-bottom 
Plexiglas restraining tubes (Braintree Scientific Inc, 
Braintree, MA, USA). The process took ~2–6 min from 
when the animal was disturbed until the first blood 
draw was acquired. If the initial blood draw required 
multiple attempts, the animal was removed from the 
study. Rats remained in the restrainer for a total of 
90 min (30 min of tight restraint, followed by 60 min of 
loosened restraint) and blood was repeatedly collected 
(250 µL) through tail vein venipuncture at 30, 60 and 
90 min, similar to previously published methods (33, 
35). The restrainer (head access rodent restrainer, 
Stoelting, Wood Dale, IL, USA) can be adjusted to four 
chamber sizes inducing varying levels of restraint. In 
the current study, tight restraint was defined by the 
smallest chamber size in which the animal could not 
adjust themselves. Loose restraint was defined by 
the second largest chamber size in which the animal 
could not turn around but could freely adjust body 
position. All blood collection occurred between 08:00 
and 12:00 h. Blood samples were collected into tubes 
coated with EDTA and kept on ice until centrifuged 
at 1300 g for 10 min. Each plasma sample was divided 
into three labeled tubes and stored at −20°C until 
processed further.
Dexamethasone treatment
At 56  DPI, rats were administered a subcutaneous dose 
of 0.1 mg/kg dexamethasone (DEX) (Dexamethasone 
Injectable sc-362917Rx, Santa Cruz Biotechnology) at 
approximately 06:00 h to investigate effectiveness of 
HPA axis negative feedback mechanisms (42). This dose 
was guided by a literature review of rats receiving DEX 
before or following experimental brain injury (33, 43, 
44, 45). Two hours postinjection, the rats were placed in 
restrainers and the restraint stress paradigm was repeated 
under the influence of DEX (see the ‘Restraint stress and 
blood collection’ section above).
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Testosterone and corticosterone
Plasma testosterone and CORT levels were quantified 
using ELISA kits purchased through Enzo Life 
Sciences, Inc (Farmingdale, NY, USA). CORT samples 
were run in triplicate and testosterone samples in 
duplicate following the manufacturer’s instructions. 
Plasma samples were diluted 1:50 per manufacturer’s 
recommendations for the CORT ELISA. Samples with 
the DEX treatment were run at higher concentrations 
(experiments were repeated at dilutions of 1:10–1:25). 
Samples for the testosterone ELISA were diluted 1:20, 
per manufacturer’s instructions.
Morphological analysis on Golgi-stained tissue
At 1 (n = 4), 7 (n = 4) and 28 (n = 3) DPI, sham- (n = 4) 
and brain-injured rats were overdosed with sodium 
pentobarbital (200 mg/kg, i.p.), decapitated and the brain 
was rapidly removed, rinsed with ddH2O, grossly dissected 
into three pieces (anterior to bregma, posterior to bregma 
and cerebellum). At least one sham-operated animal was 
used at each time point, and combined into one sham 
cohort. Tissue was processed for Golgi staining using 
manufacturer’s instructions provided in the FD Rapid 
GolgiStain Kit (FD NeuroTechnologies, Inc, Columbia, 
MD, USA). Brains were mounted on chucks with frozen 
ddH2O and then sectioned (200 µm) at −22°C on a 
cryostat and mounted on 3% gelatin-coated microscope 
slides. The slides were then stained according to FD Rapid 
GolgiStain protocol. The slides were cleared in xylene and 
cover-slipped with Permount.
Changes in PVN neuronal dendritic morphology 
were assessed over DPI using Neurolucida software 
(MicroBrightField, Inc, Colchester, VT, USA). Neurons 
were traced in three dimensions (3D; x, y, z) by an 
investigator blinded to injury status. All neurons chosen 
for reconstruction had an intact soma and the presence 
of natural ends (termination of a completely tapered 
dendrite, which can be identified by a spine or spine 
cluster or gradual narrowing). Neurons were chosen 
based on neuron cell morphology and discriminate 
staining margins of the neuron cell body and processes. 
All neuronal processes and soma were traced at 40× 
magnification, tracing the boundaries of each cell soma 
and then all emerging processes to their full extent. 3D 
reconstructions were analyzed using NeuroExplorer 
software (MicroBrightField, Inc, Colchester, VT, USA) 
to determine process quantity, branch points, process 
complexity index ((sum of terminal orders + number of 
terminals) × (total process length/number of primary 
processes)) (adapted from Pillai et  al. 2012 (46)) and 
overall process complexity (Sholl analysis). Parvocellular 
neurons, which were traced, were differentiated from 
magnocellular neurons based on localization within 
the medial PVN, which was demarcated by the 3rd 
ventricle and fornix (47, 48, 49, 50, 51). Ten neurons 
from this area were traced per animal and averaged for 
a single representative number per animal, resulting in 
a total of 150 neurons being traced. Sholl analysis was 
performed to evaluate the distribution of dendritic 
processes. A series of concentric spheres with increasing 
radius (10 µm) centered on the soma was used to assess 
the number of process crossings as a function of distance 
and space using NeuroExplorer software. Image z-stacks 
were carried out in 1 µm increments from the top-most 
process to the bottom-most process and deep-focused. 
The 3D reconstructions from Neurolucida software were 
inverted and converted to black and white in Photoshop 
(Adobe CS6).
Quantification of silver stain in the paraventricular 
nucleus
The de Olmos aminocupric silver histochemical technique 
(52, 53, 54) was carried out to assess neuropathology after 
diffuse TBI. At designated times, sham- (n = 3; one per time 
point) or brain-injured rats (n = 3 per time point) were 
overdosed with sodium pentobarbital (200 mg/kg i.p.) 
and transcardially perfused with 0.9% sodium 
chloride, followed by a fixative solution containing 4% 
paraformaldehyde and 4% sucrose in 0.1 M phosphate-
buffered saline. Fixative solution containing 15% sucrose 
was used to store the heads for 24 h after decapitation. 
The brains were extracted, placed in fresh fixative and 
shipped to Neuroscience Associates Inc (Knoxville, 
TN, USA). Brains were embedded into a single gelatin 
block (Multiblock Technology; Neuroscience Associates, 
Knoxville, TN, USA), cryosectioned, mounted and stained 
with the de Olmos aminocupric silver staining technique 
in accordance to proprietary protocols (Neuroscience 
Associates, Knoxville, TN, USA). The argyrophilic reaction 
product displayed neurons and neuronal processes, which 
were counterstained with Neutral Red and subsequently 
cover-slipped. The stained sections were analyzed in our 
laboratory similar to previously published anatomical 
regions (55).
All silver-stained slides were photographed using 
a Zeiss microscope (Imager A2) in bright-field mode 
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with a digital camera (AxioCam MRc5). A densitometric 
quantitative analysis was performed on all argyrophilic 
tissue staining at 20× magnification using ImageJ software 
(1.48v, NIH, Bethesda, MD, USA). Grayscale digital images 
were digitally thresholded to separate positive-stained 
pixels from unstained pixels, and then segmented into 
black and white pixels, indicative of positive and negative 
staining, respectively. The percentage of argyrophilic 
(black) staining was calculated using the following formula:
Four images were analyzed per animal, averaged to a 
single number and used for statistical analysis.
GFAP
At 1 (n = 3), 7 (n = 4) and 28 (n = 3) DPI, sham- (n = 4) 
and brain-injured rats were overdosed with sodium 
pentobarbital and transcardially perfused with PBS and 
4% paraformaldehyde. Brains were immersed in serial 
sucrose dilutions (15%, 30%) and cryosectioned (20 µm). 
Sections were washed 3x with 1XPBS, blocked with 4% 
v/v normal horse serum in PBS for 1 h, incubated in 
the primary antibody (rabbit anti-GFAP, 1:1000; Dako, 
catalog# Z0334) overnight at room temperature, rinsed in 
1XPBS, incubated for 1 h at room temperature with the 
secondary antibody (biotinylated horse antirabbit, 1:250; 
Vector Laboratories, Burlingame, CA, USA; Catalog# 
BA-1100), washed, blocked with 0.3% hydrogen peroxide, 
incubated with avidin/biotin complex (4°C, 20 min), 
washed and incubated with DAB (10 min). The sections 
were dehydrated with ethanol, cleared in citrisolv and 
cover-slipped using DPX. Densitometric quantitative 
analysis was performed identical to silver stain. Four to 
six images were analyzed per animal, averaged to a single 
number and used for statistical analysis.
Statistical analysis
Data are shown as mean ± s.e.m. and analyzed using 
statistical software (GraphPad-Prism 6). Differences in 
testosterone and CORT baseline and 54 DPI levels were 
measured one-way ANOVA followed by a Tukey’s multiple 
comparison test. Changes in CORT following stress and 
DEX in combination with stress were analyzed using 
a repeated measure two-way ANOVA. Nonparametric 
whisker nuisance task data were analyzed using a 
Mann–Whitney test. The average neuron process quan-
tity, branch points and process complexity index were 
subjected to statistical analysis by one-way ANOVA with 
a Tukey’s post hoc comparison. Golgi-stained morphology 
data were analyzed as a function of days postinjury and 
distance from soma using a two-way ANOVA with a 
Tukey’s post hoc comparison (Sholl analysis). Averages 
of the percent area of argyrophilic staining and GFAP 
within the paraventricular nucleus were compared using 
a one-way ANOVA. Differences in weight change were 
compared by Student’s t-test. Statistical significance was 
assigned when P < 0.05.
Results
Diffuse TBI resulted in decreased CORT but not 
testosterone at 54 DPI
Tail vein blood was collected at the time of surgery 
(05:00–09:00 h) from all rats (baseline levels). Diffuse TBI 
significantly decreased plasma CORT levels measured at 
54  DPI compared with uninjured shams and baseline 
levels (F(2,23) = 5.251, P = 0.0132; Fig. 1A). There was no 
significant difference in plasma testosterone levels in the 
brain-injured group compared with uninjured shams and 
baseline levels (F(2,29) = 1.306, P = 0.2942; Fig. 1B).
Diffuse TBI resulted in a blunted CORT response 
under stressed conditions
CORT levels were measured at 0 min (immediately 
after being placed in a restrainer), 30, 60 and 90 min 
postinduction of restraint. Both TBI and sham groups 
demonstrated increased CORT levels in response to 
restraint stress over time, indicated by a significant time 
Figure 1
Diffuse TBI resulted in decreased CORT but not testosterone at 54 DPI. At 
the time of surgery, baseline blood was collected from all rats. At 54 DPI, 
before stress, blood was collected. (A) Diffuse brain injury decreased 
plasma CORT levels in brain-injured rats compared with uninjured shams 
and baseline levels at 54 DPI. (Data presented as mean ± s.e.m.; sham n = 6, 
injured n = 6, *#P < 0.05). (B) There were no significant differences in 
plasma testosterone levels 54 DPI compared with uninjured shams and 
baseline levels. (Data presented as mean ± s.e.m.; sham n = 6, injured n = 5).
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effect (F(3,33) = 26.80, P < 0.0001; Fig.  2A). In addition, 
there was an overall significant injury effect on CORT 
levels compared with uninjured shams (F(1,11) = 4.946, 
P = 0.0480; Fig. 2A). The brain-injured rats had a blunted 
CORT response to restraint stress, and post hoc analysis 
indicated brain-injured rats had significantly lower CORT 
levels at 60 min poststress induction, compared with 
uninjured shams.
DEX suppressed CORT levels in brain-injured rats and 
uninjured shams under stressed conditions
Two hours before restraint stress at 56  DPI, rats were 
subcutaneously injected with DEX (0.1 mg/kg). Following 
DEX treatment, rats underwent the restraint stress 
paradigm (see methods). Following DEX treatment and 
restraint stress, there were no injury-induced differences 
in plasma CORT levels compared with uninjured shams 
(F(1,10) = 4.337, P = 0.0639; Fig. 2B). The DEX suppressed 
CORT even under stressed conditions indicated by 
no change in CORT levels in brain-injured or sham rats 
as a function of time (F(3,30) = 0.7555, P = 0.5272; Fig. 2B).
DEX significantly reduced CORT levels under resting 
conditions in shams but not brain-injured rats
A two-way ANOVA indicated a significant overall 
interaction between injured and sham rats at 54  DPI 
(prerestraint stress) compared with 56 DPI (following DEX 
prerestraint stress) (F(1,9) = 6.408, P = 0.0322; Fig.  2C). 
There was also a significant time effect between CORT 
levels measured at 54  DPI compared with 56  DPI 
(F(1,9) = 5.980, P = 0.0370; Fig.  2C). Sidak’s multiple 
comparisons test indicated a significant difference 
between the sham CORT levels at 54 DPI compared with 
56 DPI, but not between brain-injured 54 DPI compared 
with 56 DPI.
Diffuse TBI resulted in a significantly greater change 
in body weight compared with uninjured shams
Changes in body weight could represent injury-
related metabolism and endocrine dysfunction. In the 
first 3 days after brain injury (from 0 to 3  DPI), TBI 
significantly decreased body weight compared with 
sham (t(17) = 3.394, P = 0.0035; Fig.  3A). In contrast, 
body weight increased from 3 to 58 DPI in all animals; 
however, brain-injured rats gained significantly greater 
amounts of body weight in comparison to sham 
(t(17) = 5.066, P < 0.0001; Fig.  3B). Overall, brain injury 
led to acute decreases in body weight, which reversed 
and increased over time, such that weights of brain-
injured rats surpassed those of uninjured rats.
Figure 2
Diffuse TBI resulted in a blunted increase in CORT under stressed 
conditions, which was suppressed by DEX. (A) Restraint stress significantly 
increased plasma CORT across time in all rats, as expected. However, 
60 min after stress onset, there was a blunted increase in CORT indicated 
by significantly lower CORT levels in brain-injured rats compared with 
shams. (Data presented as mean ± s.e.m.; sham n = 7, injured n = 6, 
*P < 0.05). (B) Plasma levels of CORT were tested 2 h following 
dexamethasone (DEX) injections (0.1 mg/kg) at 56 DPI. DEX suppressed 
CORT levels similarly in both the brain-injured rats and uninjured shams 
under stressed conditions. (Data presented as mean ± s.e.m.; sham n = 6, 
injured n = 6). (C) DEX treatment significantly reduced CORT levels in the 
uninjured shams, but not brain-injured rats, under resting conditions at 
54 DPI compared with 56 DPI. (Data presented as mean ± s.e.m.; sham n = 6, 
injury n = 6; **P < 0.01).
Figure 3
Diffuse TBI resulted in a significantly greater change in body weight 
compared with uninjured shams. (A) Brain injury significantly decreased 
body weight from 0 to 3 days postinjury compared with sham. (B) Changes 
in body weights from 3 to 58 days postinjury were significantly greater in 
brain-injured rats compared with sham. (Data presented as mean ± s.e.m.; 
sham n = 10, injury n = 9; *P < 0.05).
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Sensory sensitivity was increased 28 DPI measured by 
the whisker nuisance task
We have previously reported increased sensory sensitivity 
in rats following diffuse TBI (31), as an injury-induced 
morbidity. Diffuse brain injury resulted in a significantly 
increased sensory sensitivity, assessed by the whisker 
nuisance task (WNT) at 28 DPI (U(18) = 27.00, P = 0.0424; 
Fig. 4).
Diffuse TBI induced changes in neuron process 
complexity over time in the PVN
TBI-induced damage to neurons in the PVN could 
impact HPE axis signaling involved with CORT regulation. 
The 3D traces (Fig. 5B) of parvocellular neurons (Fig. 5A) 
Figure 5
Golgi-stained neurons in the paraventricular nucleus display altered morphologies over the postinjury time course. (A) Representative neurons in the 
paraventricular nucleus of the hypothalamus are displayed at 40× magnification. (B) 3D reconstruction of neurons represented in panel A. (C) The 
number of processes were similar across all time points. (D) The number of branch points trended toward a decreased at 1 DPI, significantly increasing by 
28 DPI. (E) The average complexity index significantly differed over time postinjury, with a significant increase at 28 DPI in comparison to 1 DPI and 7 DPI. 
(F) The Sholl analysis indicates that the complexity of the neurons changes as a function of days postinjury, with a greater number of intersections at 
20 µm from soma for 28 DPI animals in comparison to sham (+) and significantly more intersections at 50 µm for shams in comparison to 1 DPI (#) 
(*P < 0.05). Bar graphs represent the mean ± s.e.m.; scale bar = 50 µm; *P < 0.05.
Figure 4
Sensory sensitivity was increased 28 days postinjury measured by the 
whisker nuisance task. Sensory sensitivity, assessed by the whisker 
nuisance task (WNT) at 28 DPI, was significantly increased compared with 
shams. These data support the late-onset of behavioral morbidity seen in 
this experimental model of diffuse TBI. (Data presented as mean ± s.e.m.; 
sham n = 10, injury n = 10; *P < 0.05).
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were quantified for average dendritic quantity, branch 
points and process complexity index at each time point 
following TBI (Fig. 5C, D and E). The number of dendrites 
was similar among treatments (sham, 1  DPI, 7  DPI, 
28  DPI), with an average of 3–4 processes per neuron 
(F(3,11) = 0.744, P = 0.548). The number of branch points 
changed over days postinjury (F(3,11) = 4.513, P = 0.027), 
with 1 day approaching significance in comparison 
to sham (sham = 14.51 ± 0.70; 1  DPI = 9.23 ± 1.6) and 
significantly increased at 28 DPI in comparison to 1 DPI 
(28  DPI = 16.40 ± 1.8; P < 0.05, Fig.  5D). The process 
complexity index also significantly changed over days 
postinjury (F(3,11) = 9.897; P = 0.002). Post hoc comparison 
indicated complexity differed between 1 DPI and 28 DPI 
as well as 7 DPI and 28 DPI (P < 0.05; Fig. 5E).
The Sholl analysis represents the number of neuron 
axonal and dendritic branches at 10 µm increments from 
the soma using concentric spheres (3D) to reflect process 
complexity (Fig.  5F). A two-way, repeated measures 
ANOVA revealed a significant effect of distance from 
the soma (F(26,297) = 191.0, P < 0.0001), indicating the 
expected outcome that neuron process complexity 
changes as a function of distance from the soma. 
Importantly, the omnibus ANOVA showed a significant 
interaction for days postinjury as a function of the neuron 
processes’ distance from the soma (F(3,297) = 9.781, 
P < 0.0001). Post hoc analyses comparing differences at 
specific distances from the soma revealed significant 
differences between sham and 28  DPI at 20 µm away 
from the soma, as well as between sham and 1  DPI 
at 50 µm away from the soma. Together, the neuron 
morphology data suggest diffuse TBI resulted in altered 
neuronal process complexity over time postinjury in a 
brain region that regulates endocrine function.
Paraventricular nucleus is absent of neuropathology 
after diffuse TBI
The de Olmos aminocupric silver stain indicates 
neuropathology based on black-colored argyrophilic 
reaction products. There was no change in the amount 
of argyrophilic reaction product over days postinjury 
(F(3,8) = 0.272; P = 0.843; Fig.  6), with an average of 
2–3% of argyrophilic reaction product accumulation 
measured across all time points, regardless of brain 
injury. These data indicate that neuropathology is not a 
significant contributor to changes in neuronal dendritic 
morphology.
Figure 6
Absence of silver staining indicates no neuropathology in the paraventricular nucleus. (A) Representative photomicrographs are displayed at 20× 
magnification. (B) Quantification of argyrophilic reaction product accumulation shows no difference between sham, 1, 7 and 28 DPI. Data were  
analyzed using a one-way ANOVA. Bar graph represents mean ± s.e.m.; scale bar = 50 µm.
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Absence of activated astrocytes in the  
paraventricular nucleus
The presence of activated astrocytes was assessed by 
immunohistochemistry for GFAP over time. At no time, 
postinjury was astrocytosis evident as a greater intensity 
or distribution of GFAP staining, indicative of activated 
astrocytes (F(3,10) = 2.719; P = 0.10). GFAP staining 
accounted for an average of 8.4% of the pixels across 
all time points, ranging from 6 to 11% between animals 
(Fig. 7). Therefore, diffuse TBI did not result in activated 
astrocytes in the paraventricular nucleus.
Discussion
Experimental diffuse TBI using midline fluid percussion 
in the rat showed evidence for CORT dysfunction at 
54 days post-TBI. Plasma CORT levels were significantly 
decreased by approximately 60% at 54  DPI compared 
with baseline and uninjured shams. However, there were 
no significant changes in testosterone, indicating that 
the hypothalamic–pituitary–gonadal axis was intact at 
this time point. Diffuse TBI led to a blunted increase in 
CORT released under acute restraint stress, indicating 
an altered neuroendocrine stress response. After 
treatment with DEX, the HPE response to restraint stress 
was suppressed in both brain-injured and uninjured 
sham  rats, indicating an intact feedback response. 
Diffuse TBI increased sensory sensitivity measured by 
the whisker nuisance task, and overall, brain-injured rats 
had a greater change in weight in comparison to sham 
at 58 DPI. The development of endocrine dysfunction, 
defined as decreased resting CORT levels and blunted 
CORT in response to stress, in brain-injured animals, 
was concomitant with altered neuron morphology in 
the paraventricular nucleus of the hypothalamus, which 
likely contributed to persistent dysfunction.
The data in this study indicate a significant decrease 
in plasma CORT, but not testosterone at a chronic time 
point following diffuse TBI in the rat. Both clinical and 
experimental data suggest that TBI induces long-term 
hypopituitarism, with measureable deficiencies in both 
testosterone and cortisol. Prospective clinical screening 
for hypopituitarism in patients with brain injuries showed 
that the most common endocrine disturbance following 
brain injury was a decrease in testosterone, measured in 
40.7% of all men, with low cortisol also being observed 
(56). Similarly, a retrospective clinical study identified 
hypopituitarism in nearly 70% of men following TBI, 
with 66% presenting low testosterone levels within the 
first 6 months of injury (57), but cortisol levels were 
not reported. In the current study, testosterone was 
not significantly lower at 54  DPI; however, CORT was 
significantly decreased compared with uninjured sham 
Figure 7
Absence of activated astrocytes in the paraventricular nucleus. (A) Representative photomicrographs of glial fibrillary acidic protein (GFAP) staining  
at 20× magnification in the PVN. (B) Quantification of GFAP staining was not different across time points (scale bar = 50 µm; Bar graph represents 
mean ± s.e.m.).
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levels at 54 DPI. It is possible that testosterone levels had 
decreased postinjury, but recovered to baseline levels by 
54 DPI in the current experimental model of TBI; future 
studies on serial plasma measurements may determine 
the course of testosterone in the brain-injured rat.
The chronic decrease in CORT measured in this 
study parallels both clinical and experimental data 
suggesting that TBI leads to chronic deficiencies in 
cortisol (56). Deficiencies in CORT include symptoms 
such as weakness, dizziness, inability to cope with 
stress, nausea and vomiting (58, 59), which parallel 
and overlap postconcussive syndrome symptoms. 
The difficulty in a differential diagnosis between TBI 
and endocrine dysfunction may reflect the broad 
epidemiology reports in the literature. Brain injury-
induced hormone deficiencies are associated with 
increased morbidity and poor recovery (60). While 
there are no data to support hormone replacement 
reducing mortality following TBI, early detection and 
supplementation can improve functional outcome and 
quality of life in TBI survivors (60).
The HPE axis is activated by stressful events that 
disrupt homeostasis, such as the restraint stress used 
in the present study (33, 61). The stress response starts 
with the activation of parvocellular secretory neurons of 
the paraventricular nucleus in the hypothalamus. These 
neurons release CRH into the superior hypophyseal 
portal vein, which stimulates the release of ACTH from 
the anterior pituitary, and finally the release of CORT 
from the adrenal gland into circulation. We found that 
restraint stress increased plasma CORT levels in all rats. 
However, 60 min after stress onset, plasma CORT levels 
were significantly lower in brain-injured rats compared 
with uninjured shams. In lateral FPI, a model of mixed 
focal and diffuse injury, CORT levels were significantly 
lower postrestraint at 7 DPI; however, as a percent increase 
from basal CORT levels, FPI increased CORT in response 
to stress (35). Restraint stress following controlled cortical 
impact (CCI) focal brain injury showed that HPE responses 
were attenuated at 7 and 21 DPI compared with sham (32). 
Similarly, 4 weeks after CCI in rats, plasma CORT response 
to 30 min of restraint stress was significantly blunted in 
brain-injured rats compared with shams (34). CORT 
response measured post-TBI can identify neuroendocrine 
dysfunction; however, acute restraint stress reveals effects 
of TBI on stress coping behavior. Our studies are the first 
to explore chronic endocrine function following diffuse 
brain injury using mFPI, and further studies are necessary 
to evaluate short-term changes to the neuroendocrine 
stress response following injury.
A potential mechanism of dysregulation of the 
endocrine system can be attributed to the injury-induced 
effects on the sensitivity of negative feedback systems to 
glucocorticoids following TBI in the rat (33). Provocative 
testing, as accomplished in the rat by dexamethasone 
(DEX) administration followed by restraint stress, can 
be used to uncover damage to the HPE axis (33, 35). The 
HPE axis is the central stress response system and works 
through a negative-feedback control. For this study, we 
administered the synthetic glucocorticoid analog, DEX, 
which we hypothesized would facilitate the negative 
feedback control of the HPE axis as demonstrated by 
lowered plasma CORT levels. As expected, restraint 
stress following DEX injections resulted in decreased 
CORT levels of both brain-injured and uninjured shams, 
without difference between groups. Similarly, DEX has 
been shown to suppress plasma CORT in rats following 
lateral FPI (35). DEX has also been shown to suppress 
CORT at 7 and 35  DPI following CCI in rats (33). The 
current study demonstrated an intact negative feedback 
system in which DEX suppressed CORT levels in brain-
injured rats following stress. Since the HPE axis is 
sensitive to feedback, it is possible that the present design 
saturated the system and occluded differences between 
groups. While the dose used in this study was guided by a 
literature search of DEX used in rats post-TBI (33, 43, 44, 
45), a lower dose of DEX may uncover subtle alterations 
and injury-induced deficits in CORT feedback.
While DEX suppressed CORT following restraint 
stress, it should be noted that the prestress baseline CORT 
levels measured at 56  DPI were lower in brain-injured 
rats compared with uninjured sham rats compared with 
their baseline CORT levels measured at 54 DPI. There was 
a significant decrease in baseline levels of plasma CORT 
prestress in the uninjured shams at 56  DPI compared 
with their baseline plasma CORT at 54  DPI, indicating 
that DEX decreased CORT and continued to suppress 
CORT production under stressed conditions. Contrarily, 
there was no difference in baseline levels of plasma CORT 
prestress at 56  DPI in brain-injured rats following DEX 
administration compared with their baseline plasma 
CORT at 54  DPI. Diffuse TBI led to decreased CORT 
levels by 56  DPI, such that negative feedback by DEX 
administration could not further suppress CORT levels.
The production and release of CORT is regulated by 
ACTH which is produced by the anterior pituitary. The 
currently observed decrease in CORT may be attributed 
to decreased ACTH production due to damage to the 
anterior pituitary. In the current study, brain-injured rats 
have increased weight gain concomitantly with chronic 
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CORT deficiencies. Damage to the anterior pituitary 
could not only decrease ACTH and CORT, but can 
contribute to decreased thyroid-stimulating hormone 
(TSH) production. TSH is a glycoprotein hormone 
secreted in the anterior pituitary and is responsible 
for stimulating metabolism of tissue throughout the 
body. Decreased TSH, referred to as hypothyroidism, 
results in weight gain, and is a common symptom of 
TBI survivors (15, 62, 63, 64). In a prospective study 
assessing functional outcome in patients with TBI, 32% 
presented hypothyroidism at 3 months postinjury (62). 
This parallels a longitudinal follow-up of adults with TBI 
showed over a median period of 38 months, 42% of TBI 
patients had gained weight (65). In the current study, 
brain-injured rats lost weight immediately following 
injury, but had an overall significant increase in weight 
at 58 DPI compared with uninjured shams. It is possible 
that damage to the anterior pituitary resulted in decreased 
TSH levels and contributed to this weight gain. Growth 
hormone deficiency has also been associated with weight 
gain; however, weight redistribution due to altered body 
composition (increased fat and decreased lean body mass) 
more accurately describes the long-term effects (66, 67). 
Alternatively, decreased activity or increased food intake 
could have contributed to weight gain. Limitations of the 
current study include group housing which prevented 
the assessment of metabolic parameters including food 
and water intake. Further studies are needed to measure 
metabolic parameters and levels of TSH and GH, and 
examine injury-induced pathology to the pituitary to 
determine if the chronic weight gain is a symptom of 
neuroendocrine dysfunction following TBI.
While there is no overt cell death in our injury model, 
our group has accumulated evidence for neuronal circuit 
dismantling leading to maladaptive circuit reorganization 
in the diffuse-injured brain (31, 38, 39). These alterations 
in neuronal and circuit function can likely be attributed 
to reparative responses to the brain injury. Consequences 
of circuit disruption following diffuse brain injury include 
increased sensory sensitivity to manual stimulation 
of the facial whiskers (31, 39, 41). Additionally, this 
sensory stimulation resulting from the whisker nuisance 
task significantly elevated plasma levels of CORT in 
brain-injured animals compared with sham animals (31). 
The once non-noxious stimulus of whisker stimulation 
now induces a stress response in the diffuse brain-
injured animal (31, 68). In the current study, we used the 
whisker nuisance task as a behavioral outcome measure 
confirming late-onset injury-induced sensory sensitivity. 
Brain injury resulted in a significantly increased 
sensory sensitivity at 28  DPI. The same animals went 
on to demonstrate decreased baseline CORT at 54 DPI, 
indicating that this late-onset of behavioral morbidity 
following diffuse TBI in the rat may be related to chronic 
endocrine dysfunction. Changes in neuronal and 
circuit function can affect hypothalamic and pituitary 
hormonal release. Chronic decreased CORT and blunted 
CORT release in response to stress are indicative of 
intact pituitary and hypothalamic neuronal connections 
with possible hypothalamic disruptions in circuitry. 
Examination of neuron process complexity of neurons 
within the PVN was used to determine structural changes 
that could contribute to the observed functional change. 
In the current study, neuron process complexity in the 
medial PVN of the hypothalamus changed over 1 month 
postinjury. These changes were most evident between 
1 and 28  DPI, with the support that neuron process 
complexity was most highly impacted within 20 µm of 
the soma. The total number of processes over time did 
not change, supporting that the changes were due to 
increased number of branches per process, rather than 
new or more processes.
The trend for fewer branch points at 1  DPI with 
more at 28  DPI could result from direct damage to the 
processes from the mechanical forces of the brain injury, 
followed by regenerative attempts to repair neuronal 
architecture at 7 and 28  DPI. However, silver staining 
indicated that there were no major changes in neuron 
pathology at 1, 7 or 28  DPI. Changes in PVN process 
complexity can also be mediated by neurotrophic factors 
produced from activated astrocytes; however, GFAP 
staining or astrocyte morphology do not support this 
mechanism either. Alternatively, changes in input from 
brain regions that regulate the PVN and release of CRH via 
feedback through glucocorticoid and mineralocorticoid 
receptors (hippocampus, amygdala, prefrontal cortex and 
midbrain) could also contribute to compensatory changes 
in neuron complexity (69, 70). There is evidence of early 
and persistent dendritic hypertrophy of pyramidal and 
spiny stellate neurons in the basolateral amygdala from 
the same cohort of animals used for Golgi staining in this 
study (71). In summary, the specific mechanisms by which 
brain injury can change neuron dendritic complexity 
within the PVN remain to be determined. However, while 
these structural changes are subtle, their contribution to 
chronic neuroendocrine disruption should be taken into 
consideration in regards to hormone regulation.
This brain region has not been explored for a 
homeostatic neuronal response in the wake of brain 
injury. While the data are indicative of injury-induced 
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changes, several limitations must be considered. First, 
the amount of plasma that could be collected which 
restricted the number of hormones (e.g. growth hormone, 
ACTH, CRH) that could be evaluated. Serial blood draws 
were necessary for the repeated sampling used during 
restraint stress and the DEX challenge. While the current 
study examined the hypothalamic PVN neurons, further 
evaluation of the pituitary itself and input regions (e.g. 
amygdala) is encouraged. Lastly, the current study did not 
test for hypogonadism. Further investigation of bound 
testosterone, free testosterone, sex hormone binding 
globulin and albumin is necessary to fully elucidate the 
role of TBI on testosterone production.
A limitation of Golgi staining is that, despite being able 
to differentiate cells by morphology, specific cell type and 
connections cannot be determined. The identification of 
parvocellular neurons based on morphology and location 
in the medial paraventricular hypothalamic nucleus is not 
fail-proof (47, 48, 49, 50). Immunohistochemical labeling 
for CRH would aid the identification of parvocellular 
neurons specifically; however, stress conditions may lead 
to other cell types (i.e. magnocellular neurons) expressing 
CRH (49). Still, the morphology of neurons represented 
in the data set is typical of neurons in the medial 
paraventricular nucleus (47, 72, 73, 74, 75).
Conclusion
Diffuse TBI resulted in chronic CORT dysfunction 
including chronic decrease in plasma CORT, blunted CORT 
response to restraint stress, increased sensory sensitivity 
to non-noxious stimuli, and increased weight gain. The 
HPE response to stress was suppressed by DEX in both 
brain-injured and uninjured shams. Diffuse TBI altered 
neuron morphology in the PVN of the hypothalamus over 
time postinjury. This suggests injury to the hypothalamus 
associated with chronic changes in morphology to the 
neurons contributes to neuroendocrine dysfunction. 
Additional studies are necessary to examine pathological 
damage to the hypothalamus and the pituitary following 
a single diffuse brain injury.
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